Marinus Pharmaceuticals' IPO

Marinus Pharmaceuticals raised a round of funding on July 31, 2014. Investors include Public.

Marinus Pharmaceuticals is a privately held specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of ganaxolone to treat serious neurological and psychiat…

Articles about Marinus Pharmaceuticals' IPO: